Evelo Biosciences, Inc.
EVLODelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001694665
Evelo Biosciences, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Nov 8, 2023; 29 institutions reported holding it in 13F filings for Q3 2023, worth $52.0M in total; no superinvestor held it.
Holders of 5% or more of EVLO
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Evelo Biosciences, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Evelo Biosciences, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
22 Schedule 13D and 13G filings on Evelo Biosciences, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Dec 11, 2023 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Nov 13, 2023 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Aug 10, 2023 | FMR LLC | 13GOld format | – | – | – | SEC |
| Jul 21, 20233:46 PM ET | Horizon Technology Finance Corp | 13GOld format | – | New | – | SEC |
| Jul 21, 2023 | HarbourVest Partners L.P. | 13GOld format | – | – | – | SEC |
| Jul 13, 2023 | Flagship Ventures Fund V, L.P. | 13D/AOld format | – | – | – | SEC |
| Jul 10, 2023 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Jun 12, 2023 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 21, 2023 | Dnca Finance | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2023 | HarbourVest Partners L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 2, 2023 | Credit Suisse AG | 13G/AOld format | – | – | – | SEC |
| Nov 21, 2022 | Dnca Finance | 13D/AOld format | – | – | – | SEC |
| Aug 23, 2022 | Dnca Finance | 13D/AOld format | – | – | – | SEC |
| Jun 1, 2022 | Flagship Ventures Fund V, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Credit Suisse AG | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2022 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Dec 28, 2021 | Dnca Finance | 13DOld format | – | New | – | SEC |
| Feb 16, 2021 | HarbourVest Partners L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Credit Suisse AG | 13GOld format | – | New | – | SEC |
| Feb 8, 2021 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 4, 2021 | Flagship Ventures Fund V, L.P. | 13D/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Evelo Biosciences, Inc. shares.
No Form 144 notices for Evelo Biosciences, Inc. are on file.